Video: Knock on Wood| Webinar: ACR/CHEST ILD Guidelines in Practice
fa-facebookfa-linkedinfa-youtube-playfa-rss

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

A Case of Nodular Rash & Painful Joints

Vania Lin, MD, MPH, Rebecca Johnson, MD, & Lisa Suter, MD  |  Issue: October 2022  |  October 10, 2022

The patient was evaluated by a dermatologist, who felt his cutaneous lesions were likely consistent with cutaneous PAN, which may be associated with group A Streptococcal infection. Differential diagnosis included panniculitis (including erythema nodosum, which may also be associated with group A Streptococcal infection, but would appear as septal panniculitis rather than medium vessel vasculitis; and erythema induratum, which may be associated with tuberculosis), ANCA-associated vasculitis, subcutaneous nodules of rheumatic fever and atypical infection. A repeat punch biopsy of the patient’s rash was performed.

FIGURE 2B: Mid to deep dermal vasculocentric mixed inflammation with relatively unaffected deep dermal vessels (H&E stain, 10x). (Click to enlarge.)

The patient was started on treatment for rheumatic fever with 10 days of cephalexin because he met the 2015 American Heart Association revised Jones major criterion of subcutaneous nodules and minor criteria of polyarthralgia, fever of ≥38.5ºC and a CRP ≥3 mg/dL. He was also started on ibuprofen and colchicine for suspected cutaneous PAN. (Note: Penicillin was avoided due to the patient’s drug allergy.)

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

The skin biopsy performed during the patient’s hospitalization showed vasculo-centric inflammation of the medium-sized vessels and relative sparing of the small vessels in the mid and deep dermis, with an inflammatory infiltration composed of lymphocytes, histiocytes, neutrophils and eosinophils in the vessel walls and fibrin obscuration of vessel lumina (see Figures 2A–C). These results were consistent with medium vessel vasculitis, with ANCA-associated vasculitis in the differential diagnosis.

The skin tissue culture grew 1+ coagulase-negative Staphylococcus, which was thought to be a contaminant. Because the patient developed new skin lesions despite the aforementioned therapy, the dermatologist recommended adding prednisone at a dose of 0.5 mg/kg daily, with planned taper over 28 days. The patient was discharged following clinical improvement on steroids, with outpatient rheumatology and dermatology follow-up.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Discussion

FIGURE 2C: Vasculocentric inflammation consisting of lymphocytes, histiocytes, neutrophils, and eosinophils with obscuration of vessel walls and fibrin deposition (H&E stain, 20x).

PAN is a rare, necrotizing, predominantly medium-vessel vasculitis first described in 1852, with its cutaneous-limited form described in 1931. Characteristic histopathology of cutaneous PAN is leukocytoclastic vasculitis in small- to medium-sized arterioles of deep dermis or hypodermis, with or without fibrinoid necrosis. Most cases of cutaneous PAN are idiopathic, but up to 40% may be associated with infection (group A Streptococcus, hepatitis B, hepatitis C, recurrent urinary tract infections, parvovirus B19 and Mycobacterium tuberculosis), as well as inflammatory bowel disease and long-term exposure to minocycline.5,6

Page: 1 2 3 4 5 | Single Page
Share: 

Filed under:ConditionsVasculitis Tagged with:case reportFellowsFellows Forumpolyarteritis nodosa

Related Articles

    Case Report: Diagnosing, Treating Hepatitis B-Linked Polyarteritis Nodosa

    September 17, 2019

    Hepatitis B virus (HBV) associated polyarteritis nodosa (PAN) is an increasingly rare vasculitis in developed countries due to advances in HBV vaccination and antiviral therapy. However, the condition does persist, and rheumatologists should consider it when evaluating vasculitis cases. Below, we discuss a case that illustrates the varied clinical presentations PAN can encompass. A high…

    Medium-sized blood vessels are seen in the dermis and at the dermal-subcutaneous junction. The black arrow identifies a venule, and the blue arrow points to a fibrin deposition in the vessel wall. Extravasated neutrophils and erythrocytes are seen in the interstitium.

    Case Report: A Polyarteritis Nodosa Conundrum

    March 14, 2022

    Polyarteritis nodosa (PAN) is a systemic necrotizing vasculitis that typically affects medium-sized muscular arteries. The clinical subsets of PAN are idiopathic, generalized, secondary hepatitis B virus (HBV) associated and cutaneous PAN. These clinical subsets are important because of their therapeutic implications. Virtually any organ system can be affected in generalized PAN, but this vasculitis tends…

    Vasculitis Guidelines in Focus, Part 4: Polyarteritis Nodosa

    September 22, 2021

    Jason Springer, MD, MS, served as one of the lead authors of the ACR/VF guidelines for polyarteritis nodosa (PAN), and talks about the recommendations specific to PAN here.

    Alisusha; Trueffelpix / shutterstock.com

    3 New Vasculitis Guidelines Discussed

    May 13, 2021

    The ACR, in concert with the Vasculitis Foundation, released three new vasculitis guidelines online first in July, with a fourth slated for publication by the end of the year. These are the first ever to be produced and endorsed by the ACR and the Vasculitis Foundation. Although most of the recommendations are conditional, due to…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
fa-facebookfa-linkedinfa-youtube-playfa-rss
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences